Statistics for Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis
Total visits
| views | |
|---|---|
| Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis | 2 |
Total visits per month
| views | |
|---|---|
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
File Visits
| views | |
|---|---|
| java.util.UUID:5bf69a23-6e9c-49b2-ae07-2c70a06d0b5f | 30 |
| java.util.UUID:ba5cf048-4571-4dd1-92f8-21a81b85c086 | 12 |
| java.util.UUID:724512e5-8b1d-4fb2-a126-b1144c62c4d9 | 6 |
| Lukin2022Comparative-AAM.pdf | 2 |
Top country views
| views | |
|---|---|
| United States | 2 |
Top city views
| views | |
|---|---|
| Greenwood | 2 |